CN111357893A - 一种松露口服液及其制备方法 - Google Patents
一种松露口服液及其制备方法 Download PDFInfo
- Publication number
- CN111357893A CN111357893A CN202010232810.5A CN202010232810A CN111357893A CN 111357893 A CN111357893 A CN 111357893A CN 202010232810 A CN202010232810 A CN 202010232810A CN 111357893 A CN111357893 A CN 111357893A
- Authority
- CN
- China
- Prior art keywords
- parts
- truffle
- oral liquid
- extracting
- yeast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 43
- 241000609666 Tuber aestivum Species 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 25
- 239000000843 powder Substances 0.000 claims abstract description 23
- 240000000759 Lepidium meyenii Species 0.000 claims abstract description 22
- 235000000421 Lepidium meyenii Nutrition 0.000 claims abstract description 22
- 235000012902 lepidium meyenii Nutrition 0.000 claims abstract description 22
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 20
- 244000197580 Poria cocos Species 0.000 claims abstract description 19
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 19
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 19
- 241001327634 Agaricus blazei Species 0.000 claims abstract description 18
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 18
- 240000002605 Lactobacillus helveticus Species 0.000 claims abstract description 18
- 235000013967 Lactobacillus helveticus Nutrition 0.000 claims abstract description 18
- 241000237502 Ostreidae Species 0.000 claims abstract description 18
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 18
- 241000121220 Tricholoma matsutake Species 0.000 claims abstract description 18
- 235000015203 fruit juice Nutrition 0.000 claims abstract description 18
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims abstract description 18
- 229940054346 lactobacillus helveticus Drugs 0.000 claims abstract description 18
- 235000020636 oyster Nutrition 0.000 claims abstract description 18
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 17
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 17
- 241000133134 Saussurea Species 0.000 claims abstract description 17
- 235000020733 paullinia cupana extract Nutrition 0.000 claims abstract description 17
- 240000002769 Morchella esculenta Species 0.000 claims abstract description 16
- 235000002779 Morchella esculenta Nutrition 0.000 claims abstract description 16
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 15
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 15
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 15
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims abstract description 15
- 240000000599 Lentinula edodes Species 0.000 claims abstract description 14
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 14
- 238000000605 extraction Methods 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 241001145025 Saussurea involucrata Species 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 238000012216 screening Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 5
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 235000001188 Peltandra virginica Nutrition 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 4
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 3
- 244000182216 Mimusops elengi Species 0.000 claims description 3
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 3
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000009423 ventilation Methods 0.000 claims description 2
- 241000186016 Bifidobacterium bifidum Species 0.000 claims 1
- 241000756042 Polygonatum Species 0.000 claims 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 description 12
- 230000036039 immunity Effects 0.000 description 10
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 9
- 230000002708 enhancing effect Effects 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- 206010016256 fatigue Diseases 0.000 description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000036299 sexual function Effects 0.000 description 3
- 210000001082 somatic cell Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- MDKCFLQDBWCQCV-UHFFFAOYSA-N benzyl isothiocyanate Chemical compound S=C=NCC1=CC=CC=C1 MDKCFLQDBWCQCV-UHFFFAOYSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 208000019116 sleep disease Diseases 0.000 description 2
- 208000020685 sleep-wake disease Diseases 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 208000000044 Amnesia Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 241000221638 Morchella Species 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- QAADZYUXQLUXFX-UHFFFAOYSA-N N-phenylmethylthioformamide Natural products S=CNCC1=CC=CC=C1 QAADZYUXQLUXFX-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000013341 fat substitute Nutrition 0.000 description 1
- 239000003778 fat substitute Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 125000004383 glucosinolate group Chemical group 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000003652 hormone inhibitor Substances 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000022119 inability to concentrate Diseases 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 230000007310 pathophysiology Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/147—Helveticus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种松露口服液及其制备方法,所述的松露口服液,包括如下重量份数的原料组分:松露1.5‑4份,松茸1.5‑4份,姬松茸1.5‑4份,羊肚菌0.5‑1.5份,枸杞子6‑12份,虫蛹草0.5‑1.5份,雪莲培养物1.5‑4份,茯苓6‑12份,香菇6‑12份,果汁8‑10份,酵母β‑葡聚糖1.5‑4份,牡蛎肽1.5‑4份,瓜拉纳提取物0.1‑0.5份,瑞士乳杆菌0.5‑1份,双歧杆菌0.5‑1份,低聚木糖2‑4份,低聚异麦芽糖2‑4份,玛咖粉0.5‑4份,黄精0.5‑1.5份。本发明提供的松露口服液不含有防腐剂、人工色素,具有提高机体免疫力,增强人体新陈代谢,延缓衰老,防癌抗癌,降血压、降血脂、降胆固醇,改善胃肠道功能,增强男性性功能,抗疲劳等功效。
Description
技术领域
本发明涉及口服液技术领域,具体涉及一种松露口服液及其制备方法。
背景技术
亚健康的主要特征包括:身心上不适应的感觉所反映出来的种种症状,如疲劳、虚弱、免疫力低下等,其状况在相当时期内难以明确;与年龄不相适应的组织结构或生理功能减退所致的各种虚弱表现;微生态失衡状态;某些疾病的病前生理病理学改变。
临床表现多种多样,躯体方面可表现为疲乏无力、肌肉及关节酸痛、头昏头痛、心悸胸闷、睡眠紊乱、食欲不振、脘腹不适、便溏便秘、性功能减退、怕冷怕热、易于感冒、眼部干涩等;心理方面可表现有情绪低落、心烦意乱、焦躁不安、急躁易怒、恐惧胆怯、记忆力下降、注意力不能集中、精力不足、反应迟钝等。
目前,市面上还没有一种松露口服液可以改善人体亚健康状态,具有提高机体免疫力,增强人体新陈代谢,延缓衰老,防癌抗癌,降血压、降血脂、降胆固醇,改善胃肠道功能,增强男性性功能,抗疲劳,补脑提神等功效。
发明内容
针对现有技术中的缺陷,本发明提供一种松露口服液,所述的松露口服液,包括如下重量份数的原料组分:松露1.5-4份,松茸1.5-4份,姬松茸1.5-4份,羊肚菌0.5-1.5份,枸杞子6-12份,虫蛹草0.5-1.5份,雪莲培养物1.5-4份,茯苓6-12份,香菇6-12份,果汁8-10份,酵母β-葡聚糖1.5-4份,牡蛎肽1.5-4份,瓜拉纳提取物0.1-0.5份,瑞士乳杆菌0.5-1份,双歧杆菌0.5-1份,低聚木糖2-4份,低聚异麦芽糖2-4份,玛咖粉0.5-4份,黄精0.5-1.5份。
优选地,所述的松露口服液,包括如下重量份数的原料组分:松露1.8-3.3份,松茸1.8-3.3份,姬松茸1.8-3.3份,羊肚菌0.7-1.25份,枸杞子6-11.1份,虫蛹草0.5-1.2份,雪莲培养物1.8-3.3份,茯苓6-12份,香菇6-12份,果汁8-10份,酵母β-葡聚糖2.5-3.5份,牡蛎肽2.5-3.5份,瓜拉纳提取物0.2-0.4份,瑞士乳杆菌0.5-0.8份,双歧杆菌0.5-0.8份,低聚木糖2.5-3.5份,低聚异麦芽糖2.5-3.5份,玛咖粉0.5-4份,黄精0.5-1.5份。
优选地,所述的松露口服液,包括如下重量份数的原料组分:松露1.8份,松茸1.8份,姬松茸1.8份,羊肚菌0.7份,枸杞子6份,虫蛹草0.5份,雪莲培养物1.8份,茯苓6份,香菇6份,果汁10份,酵母β-葡聚糖2.5份,牡蛎肽2.5份,瓜拉纳提取物0.2份,瑞士乳杆菌0.5份,双歧杆菌0.5份,低聚木糖2.5份,低聚异麦芽糖2.5份,玛咖粉2份,黄精1份。
优选地,所述的松露口服液,包括如下重量份数的原料组分:松露3.3份,松茸3.3份,姬松茸3.3份,羊肚菌1.25份,枸杞子11.1份,虫蛹草1.2份,雪莲培养物3.3份,茯苓12份,香菇12份,果汁10份,酵母β-葡聚糖3.5份,牡蛎肽3.5份,瓜拉纳提取物0.4份,瑞士乳杆菌0.8份,双歧杆菌0.8份,低聚木糖3.5份,低聚异麦芽糖3.5份,玛咖粉2份,黄精1份。
优选地,所述的松露口服液,包括如下重量份数的原料组分:松露2.5份,松茸2.5份,姬松茸2.5份,羊肚菌0.98份,枸杞子8.5份,虫蛹草0.75份,雪莲培养物2.5份,茯苓9份,香菇9份,果汁10份,酵母β-葡聚糖3份,牡蛎肽3份,瓜拉纳提取物0.3份,瑞士乳杆菌0.6份,双歧杆菌0.6份,低聚木糖3份,低聚异麦芽糖3份,玛咖粉2份,黄精1份。
上述的松露口服液的制备方法,步骤如下:S1.筛选和清洗:筛选出优质的松露,松茸,姬松茸,羊肚菌,枸杞子,虫蛹草,雪莲培养物,黄精,茯苓,香菇,后清洗干净,制得干净的原料;S2.烘干和粉碎:将S1中得到的干净的原料烘干,粉碎,制得原料粉末;S3.提取:将S2中制得的原料粉末中加入清水,浸泡,加热提取,过滤,重复提取3次,将3次获得的提取液混合,制得提取液A和残渣;S4.超临界CO2提取:将S3中的残渣进行超临界CO2提取,制得提取液B;S5.浓缩和混合:将提取液A和提取液B混合,搅拌均匀,进行减压浓缩,制得浓缩液,在浓缩液中加入果汁份,酵母β-葡聚糖,玛咖粉,牡蛎肽,瓜拉纳提取物,瑞士乳杆菌,双歧杆菌,低聚木糖和低聚异麦芽糖,搅拌均匀,制得口服液;S6.灌装:将口服液灌装至瓶中,再将瓶盖密封到所述瓶上,得到瓶装口服液;S7.高温灭菌:将瓶装口服液于115℃水蒸汽下,灭菌30分钟。S8.包装和入库:将灭菌后的瓶装口服液进行包装,置于避光通风处,在低于30℃的温度下贮藏。
步骤S3所述的加热提取为加热至90-95摄氏度,提取2小时。
步骤S4所述的超临界CO2提取的条件为压力40MPa,温度40℃。
步骤S5所述的减压浓缩为-0.08到-0.1MPa下浓缩至相对密度为0.8-1.2。
本发明中所述的原料组分的各自的功效和作用
松露:增强免疫力,抗衰老,抗疲劳,助阳,调节内分泌。
松茸:补肾强体,理气化痰,用于治疗腰膝酸软,头晕目眩,恶心呕吐,肢体困倦。
姬松茸:具有健脑,消炎,益肾,降血糖,改善糖尿病,降胆固醇,增强精力,改善动脉硬化,防治心血管病等功效。
枸杞子:滋肝补肾,益肾明目,用于虚劳精亏,腰膝酸软,眩晕耳鸣,阳痿遗精,血虚萎黄,目昏不明。
羊肚菌:益肠胃,助消化,补肾壮阳,补脑提神。
虫蛹草:保肺益肾养肝、止咳平喘祛痰、润肤防皱抗衰老、抗菌抗炎、镇静、扩张血管、降低血压、降低血糖、抗疲劳、耐缺氧等作用。
茯苓:增强免疫力、抗肿瘤以及镇静、降血糖,可松弛消化道平滑肌,抑制胃酸分泌,防止肝细胞坏死,抗菌等功效。
香菇:提高机体免疫功能,延缓衰老,防癌抗癌,降血压、降血脂、降胆固醇,又可预防动脉硬化、肝硬化等疾病。
雪莲培养物:甄选出最佳的野生天山雪莲种子,保证了雪莲体细胞的基因优势,严格控制培养条件,使雪莲细胞能够获得最好的生存环境和充足的营养素,保证了植物体细胞的超高品质,经过上千次的筛选、培养、再筛选,获得的雪莲体细胞药用成份较野生雪莲更适合人体吸收,大大提高了生物利用度。
果汁:复合柠檬、苹果等多种具有食疗作用的水果的果汁,还起到调味作用。
酵母β-葡聚糖:具有增强免疫力,抗感染,降低血脂等功效,还具有脂肪样口感,可作为低卡路里食品添加剂,作为脂肪替代物使用。
牡蛎肽:增强男性性功能,保护肝脏,增强免疫力,降血糖,预防心脑血管疾病,抗肿瘤。
低聚木糖:减少有毒发酵产物及有害细菌酶的产生,抑制病原菌和腹泻,防止便秘,保护肝脏功能,降低血压,降低血清胆固醇,能增强机体免疫力,抗癌。而且它可以选择性地促进肠道双歧杆菌的增殖活性,与双歧杆菌配伍具有协效作用。
低聚异麦芽糖:低聚异麦芽糖有上述许多优良的性质和保健生理功能,适合代替部分蔗糖,添加到各种饮料、食品中作为甜味剂使用。
瑞士乳杆菌:有多种具有增强人体新陈代谢,促进免疫、激素、酶抑制剂,抗抗菌,抗病毒和抗气蚀作用的生物活性肽。能够有效的降低血压的同时,还有缓解高血压,缓解紧张,改善脑功能,提高记忆和学习能力的功能。
双歧杆菌:双歧杆菌是一种重要的肠道有益微生物,对人体健康具有生物屏障、营养作用、抗肿瘤作用、免疫增强作用、改善胃肠道功能、抗衰老等多种重要的生理功能。
黄精:具有补气养阴,健脾,润肺,益肾的作用,用于壮筋骨,益精髓,治脾胃虚弱,体倦无力,治肺劳咳血,赤白带,高脂血症等病症
玛咖:玛咖根中蛋白质含量为10%以上,59%的碳水化合物;8.5%的纤维,内含丰富的锌、钙、铁、钛、铷、钾、钠、铜、锰、镁、锶、磷、碘等矿物质,并含有维生素C、B1、B2、B6、A、E、B12、B5,脂肪含量不高但其中多为不饱和脂肪酸,亚油酸和亚麻酸的含量达53%以上,天然活性成份包括生物碱、芥子油苷及其分解产物异硫氰酸苄酯、甾醇、多酚类物质等。其中还含有玛卡酰胺和玛卡稀,这两种物质对平衡人体荷尔蒙分泌有显著作用。
本发明的有益效果体现在:本发明提供的松露口服液不含有防腐剂、人工色素,具有提高机体免疫力,增强人体新陈代谢,延缓衰老,防癌抗癌,降血压、降血脂、降胆固醇,改善胃肠道功能,增强男性性功能,抗疲劳,补脑提神等功效。适用于体弱或久病体虚人群(易生病、精神萎靡、睡眠障碍)、有轻微感冒症状(鼻涕不止、咽喉肿痛)或有炎症的人群(牙龈肿痛、伤口发炎、肠胃炎)。
具体实施方式
下面将对本发明技术方案的实施例进行详细的描述。以下实施例仅用于更加清楚地说明本发明的技术方案,因此只作为示例,而不能以此来限制本发明的保护范围。
需要注意的是,除非另有说明,本申请使用的技术术语或者科学术语应当为本发明所属领域技术人员所理解的通常意义。
实施例1
一种松露口服液包括如下重量份数的原料组分:松露1.8份,松茸1.8份,姬松茸1.8份,羊肚菌0.7份,枸杞子6份,虫蛹草0.5份,雪莲培养物1.8份,茯苓6份,香菇6份,果汁10份,酵母β-葡聚糖2.5份,牡蛎肽2.5份,瓜拉纳提取物0.2份,瑞士乳杆菌0.5份,双歧杆菌0.5份,低聚木糖2.5份,低聚异麦芽糖2.5份,玛咖粉2份,黄精1份。
上述的松露口服液的制备方法,步骤如下:S1.筛选和清洗:筛选出优质的松露,松茸,姬松茸,羊肚菌,枸杞子,虫蛹草,雪莲培养物,黄精,茯苓,香菇,后清洗干净,制得干净的原料;S2.烘干和粉碎:将S1中得到的干净的原料烘干,粉碎,制得原料粉末;S3.提取:将S2中制得的原料粉末中加入清水,浸泡,加热提取,过滤,重复提取3次,将3次获得的提取液混合,制得提取液A和残渣;S4.超临界CO2提取:将S3中的残渣进行超临界CO2提取,制得提取液B;S5.浓缩和混合:将提取液A和提取液B混合,搅拌均匀,进行减压浓缩,制得浓缩液,在浓缩液中加入果汁份,酵母β-葡聚糖,玛咖粉,牡蛎肽,瓜拉纳提取物,瑞士乳杆菌,双歧杆菌,低聚木糖和低聚异麦芽糖,搅拌均匀,制得口服液;S6.灌装:将口服液灌装至瓶中,再将瓶盖密封到所述瓶上,得到瓶装口服液;S7.高温灭菌:将瓶装口服液于115℃水蒸汽下,灭菌30分钟。S8.包装和入库:将灭菌后的瓶装口服液进行包装,置于避光通风处,在低于30℃的温度下贮藏。
步骤S3所述的加热提取为加热至90-95摄氏度,提取2小时。
步骤S4所述的超临界CO2提取的条件为压力40MPa,温度40℃。
步骤S5所述的减压浓缩为-0.08到-0.1MPa下浓缩至相对密度为0.8-1.2。
实施例2
本实施例与实施例1的不同之处在于:一种松露口服液包括如下重量份数的原料组分:松露3.3份,松茸3.3份,姬松茸3.3份,羊肚菌1.25份,枸杞子11.1份,虫蛹草1.2份,雪莲培养物3.3份,茯苓12份,香菇12份,果汁10份,酵母β-葡聚糖3.5份,牡蛎肽3.5份,瓜拉纳提取物0.4份,瑞士乳杆菌0.8份,双歧杆菌0.8份,低聚木糖3.5份,低聚异麦芽糖3.5份,玛咖粉2份,黄精1份。
实施例3
本实施例与实施例1的不同之处在于:一种松露口服液包括如下重量份数的原料组分:松露2.5份,松茸2.5份,姬松茸2.5份,羊肚菌0.98份,枸杞子8.5份,虫蛹草0.75份,雪莲培养物2.5份,茯苓9份,香菇9份,果汁10份,酵母β-葡聚糖3份,牡蛎肽3份、瓜拉纳提取物0.3份,瑞士乳杆菌0.6份,双歧杆菌0.6份,低聚木糖3份,低聚异麦芽糖3份,玛咖粉2份,黄精1份。
试验例
本发明实施例1中制得的松露口服液使用效果分析,见表1:
使用方法:每日3次,每次1瓶,每瓶50ml。
表1
最后应说明的是:以上各实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述各实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分或者全部技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的范围,其均应涵盖在本发明的权利要求和说明书的范围当中。
Claims (9)
1.一种松露口服液,其特征在于:所述的松露口服液,包括如下重量份数的原料组分:松露1.5-4份,松茸1.5-4份,姬松茸1.5-4份,羊肚菌0.5-1.5份,枸杞子6-12份,虫蛹草0.5-1.5份,雪莲培养物1.5-4份,茯苓6-12份,香菇6-12份,果汁8-10份,酵母β-葡聚糖1.5-4份,牡蛎肽1.5-4份,瓜拉纳提取物0.1-0.5份,瑞士乳杆菌0.5-1份,双歧杆菌0.5-1份,低聚木糖2-4份,低聚异麦芽糖2-4份,玛咖粉0.5-4份,黄精0.5-1.5份。
2.根据权利要求1所述的松露口服液,其特征在于:所述的松露口服液,包括如下重量份数的原料组分:松露1.8-3.3份,松茸1.8-3.3份,姬松茸1.8-3.3份,羊肚菌0.7-1.25份,枸杞子6-11.1份,虫蛹草0.5-1.2份,雪莲培养物1.8-3.3份,茯苓6-12份,香菇6-12份,果汁8-10份,酵母β-葡聚糖2.5-3.5份,牡蛎肽2.5-3.5份,瓜拉纳提取物0.2-0.4份,瑞士乳杆菌0.5-0.8份,双歧杆菌0.5-0.8份,低聚木糖2.5-3.5份,低聚异麦芽糖2.5-3.5份,玛咖粉0.5-4份,黄精0.5-1.5份。
3.根据权利要求2所述的松露口服液,其特征在于:所述的松露口服液,包括如下重量份数的原料组分:松露1.8份,松茸1.8份,姬松茸1.8份,羊肚菌0.7份,枸杞子6份,虫蛹草0.5份,雪莲培养物1.8份,茯苓6份,香菇6份,果汁10份,酵母β-葡聚糖2.5份,牡蛎肽2.5份,瓜拉纳提取物0.2份,瑞士乳杆菌0.5份,双歧杆菌0.5份,低聚木糖2.5份,低聚异麦芽糖2.5份,玛咖粉2份,黄精1份。
4.根据权利要求2所述的松露口服液,其特征在于:所述的松露口服液,包括如下重量份数的原料组分:松露3.3份,松茸3.3份,姬松茸3.3份,羊肚菌1.25份,枸杞子11.1份,虫蛹草1.2份,雪莲培养物3.3份,茯苓12份,香菇12份,果汁10份,酵母β-葡聚糖3.5份,牡蛎肽3.5份,瓜拉纳提取物0.4份,瑞士乳杆菌0.8份,双歧杆菌0.8份,低聚木糖3.5份,低聚异麦芽糖3.5份,玛咖粉2份,黄精1份。
5.根据权利要求2所述的松露口服液,其特征在于:所述的松露口服液,包括如下重量份数的原料组分:松露2.5份,松茸2.5份,姬松茸2.5份,羊肚菌0.98份,枸杞子8.5份,虫蛹草0.75份,雪莲培养物2.5份,茯苓9份,香菇9份,果汁10份,酵母β-葡聚糖3份,牡蛎肽3份,瓜拉纳提取物0.3份,瑞士乳杆菌0.6份,双歧杆菌0.6份,低聚木糖3份,低聚异麦芽糖3份,玛咖粉2份,黄精1份。
6.权利要求1-5任意一项所述的松露口服液的制备方法,其特征在于:所述的制备方法,步骤如下:S1.筛选和清洗:筛选出优质的松露,松茸,姬松茸,羊肚菌,枸杞子,虫蛹草,雪莲培养物,黄精,茯苓和香菇,清洗干净,制得干净的原料;S2.烘干和粉碎:将S1中得到的干净的原料烘干,粉碎,制得原料粉末;S3.提取:将S2中制得的原料粉末中加入清水,浸泡,加热提取,过滤,重复提取3次,将3次获得的提取液混合,制得提取液A和残渣;S4.超临界CO2提取:将S3中的残渣进行超临界CO2提取,制得提取液B;S5.浓缩和混合:将提取液A和提取液B混合,搅拌均匀,进行减压浓缩,制得浓缩液,在浓缩液中加入果汁,酵母β-葡聚糖,玛咖粉,牡蛎肽,瓜拉纳提取物,瑞士乳杆菌,双歧杆菌,低聚木糖和低聚异麦芽糖,搅拌均匀,制得口服液;S6.灌装:将口服液灌装至瓶中,再将瓶盖密封到所述瓶上,得到瓶装口服液;S7.高温灭菌:将瓶装口服液于115℃水蒸汽下,灭菌30分钟;S8.包装和入库:将灭菌后的瓶装口服液进行包装,置于避光通风处,在低于30℃的温度下贮藏。
7.根据权利要求6所述的制备方法,其特征在于:步骤S3所述的加热提取为加热至90-95℃,提取2小时。
8.根据权利要求6所述的制备方法,其特征在于:步骤S4所述的超临界CO2提取的条件为压力40MPa,温度40℃。
9.根据权利要求6所述的制备方法,其特征在于:步骤S5所述的减压浓缩为-0.08到-0.1MPa下浓缩至相对密度为0.8-1.2。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010232810.5A CN111357893A (zh) | 2020-03-28 | 2020-03-28 | 一种松露口服液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010232810.5A CN111357893A (zh) | 2020-03-28 | 2020-03-28 | 一种松露口服液及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111357893A true CN111357893A (zh) | 2020-07-03 |
Family
ID=71198947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010232810.5A Pending CN111357893A (zh) | 2020-03-28 | 2020-03-28 | 一种松露口服液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111357893A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112843122A (zh) * | 2021-03-17 | 2021-05-28 | 广州泽力医药科技有限公司 | 内分泌调节组合物及其应用和植物饮料 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107788315A (zh) * | 2017-11-27 | 2018-03-13 | 威海养经堂医药科技有限公司 | 一种蛹虫草枸杞多糖固体饮料 |
CN109645200A (zh) * | 2019-01-07 | 2019-04-19 | 江苏金丝利药业股份有限公司 | 一种玛咖压片糖果及其制备方法 |
CN109966387A (zh) * | 2019-03-29 | 2019-07-05 | 广东澳思瑞雅健康美容生物科技有限公司 | 一种调养五脏和养心安神的配方及制备方法 |
CN110694045A (zh) * | 2019-09-19 | 2020-01-17 | 杭州上医御本医药保健品科技开发有限公司 | 一种有益于提高***质量、抗疲劳、增强免疫力的医用营养品及其制备方法 |
-
2020
- 2020-03-28 CN CN202010232810.5A patent/CN111357893A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107788315A (zh) * | 2017-11-27 | 2018-03-13 | 威海养经堂医药科技有限公司 | 一种蛹虫草枸杞多糖固体饮料 |
CN109645200A (zh) * | 2019-01-07 | 2019-04-19 | 江苏金丝利药业股份有限公司 | 一种玛咖压片糖果及其制备方法 |
CN109966387A (zh) * | 2019-03-29 | 2019-07-05 | 广东澳思瑞雅健康美容生物科技有限公司 | 一种调养五脏和养心安神的配方及制备方法 |
CN110694045A (zh) * | 2019-09-19 | 2020-01-17 | 杭州上医御本医药保健品科技开发有限公司 | 一种有益于提高***质量、抗疲劳、增强免疫力的医用营养品及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112843122A (zh) * | 2021-03-17 | 2021-05-28 | 广州泽力医药科技有限公司 | 内分泌调节组合物及其应用和植物饮料 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105918821A (zh) | 具有降三高并提高免疫力功能的综合酵素液及其制备方法 | |
CN104824548B (zh) | 枸杞复合保健酵素及其制备方法 | |
CN108812909B (zh) | 一种改善偏食或厌食的辅食营养补充品及其制备方法 | |
CN102233018A (zh) | 番木瓜科和蔷薇科植物木瓜发酵素,其制备方法及其用途 | |
US9950024B2 (en) | Traditional Chinese medicine composition and the use thereof | |
CN102805170B (zh) | 一种红茶菌饮料及其制备工艺及其应用 | |
CN102726565A (zh) | 荞菊养生茶及其制备方法 | |
CN103609696A (zh) | 一种益智明目型酸奶及加工方法 | |
CN104305427A (zh) | 葡萄红茶菌饮料 | |
CN103598333A (zh) | 一种健脾消食的酸奶及其加工工艺 | |
CN106072527A (zh) | 一种排毒养颜的纳豆组方及其制备方法 | |
CN111387381A (zh) | 蓝靛果复合果汁饮料及其制备方法 | |
CN106901115A (zh) | 一种山楂蓝莓汁饮料及其制备方法 | |
CN105768070A (zh) | 一种调理肠胃的功能性营养食品 | |
CN114246222A (zh) | 一种具有安神助眠、改善胃肠道功能的植物基酸奶及其制备方法 | |
CN113455602A (zh) | 一种植物酵素肽饮品及其制备方法 | |
CN111357893A (zh) | 一种松露口服液及其制备方法 | |
CN105779246A (zh) | 一种车厘子醋饮料 | |
KR20110118911A (ko) | 한약재를 이용한 유산균 곡물 발효 추출물 및 이의 제조방법 | |
CN107125527A (zh) | 一种可供糖尿病人使用的无糖发酵饮品及其制备方法 | |
CN105747063A (zh) | 一种苹果瓜发酵碳酸饮料 | |
CN112369546A (zh) | 一种藏红花葛根枸杞子固体饮料的组分及其制备方法 | |
CN105341911A (zh) | 一种杏鲍菇土茯苓发酵饮料的加工方法 | |
CN111616222A (zh) | 一种蛋白花生饮料配方及其制备方法 | |
CN110801002A (zh) | 一种鹿茸滋补酵素及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200703 |